세계의 수면 보조제 시장 보고서(2025년)
Sleeping Aids Global Market Report 2025
상품코드 : 1821652
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수면 보조제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 8.8%를 나타낼 것으로 예측되고 1,326억 9,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 웰빙 및 자기 관리 트렌드, 정신 건강 인식, 가정 기반 수면 솔루션, 맞춤형 수면 솔루션, 자연적이고 비침습적인 옵션 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 웰빙 및 자기 관리 강조, 기술 통합, 수면 위생 교육, 안전에 주력하는 규제가 포함됩니다.

향후 5년간 8.8% 성장 예측은 이 시장에 대한 이전 추정치 대비 0.3% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 인도와 캐나다에서 원산되는 처방 등급 멜라토닌 및 비벤조디아제핀계 진정제의 비용을 증가시켜 미국 시장에 부정적 영향을 미칠 것으로 예상됩니다. 이는 불면증 환자의 치료 순응도를 감축하고 정신 건강 서비스 비용을 상승시킬 것입니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더 광범위하게 나타날 것입니다.

수면 보조제 시장의 성장 궤적은 수면 장애 발생률 증가에 상당한 영향을 받을 것으로 예상됩니다. 수면 부족에서 비롯된 수면 장애는 전반적인 건강에 중대한 영향을 미칩니다. 수면 보조제는 수면 부족으로 인한 인지 기능 저하를 완화할 뿐만 아니라 수면의 질을 단기적으로 촉진하는 데 중요한 역할을 합니다. 특히 2022년 1월 기준, 국립생물공학정보센터(NCBI) 자료에 따르면 다양한 집단에서 수면 문제 유병률이 확인되었으며, 코로나19 환자의 경우 52.39%, 아동 및 청소년 45.96%, 의료 종사자 42.47%, 의료적 필요가 있는 특수 집단 41.50%, 대학생 41.16%, 일반 인구 36.73%로 나타났습니다. 이처럼 수면 장애가 증가하는 현상은 수면 보조제에 대한 수요가 높아지고 있음을 보여주며, 이를 필수적인 해결책으로 자리매김하게 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

The term 'sleeping aids' encompasses a range of psychoactive medications aimed at addressing insomnia and occasional sleep disturbances. These aids are designed to alleviate daytime fatigue and cognitive impairment caused by sleep disruptions.

Different categories of sleeping aids include mattresses, pillows, sleep laboratories, medications (both prescription and over-the-counter), herbal remedies, and devices for conditions like sleep apnea. 'Medications' encompass formulations comprising various active and inactive ingredients tailored to address specific sleep-related issues such as insomnia, sleep deprivation, narcolepsy, and sleep apnea. These aids are commonly available through hospital pharmacies, retail outlets, online platforms, drug stores, and similar channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sleeping aids market research report is one of a series of new reports from The Business Research Company that provides sleeping aids market statistics, including sleeping aids industry global market size, regional shares, competitors with a sleeping aids market share, detailed sleeping aids market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping aids industry. This sleeping aids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sleeping aids market size has grown strongly in recent years. It will grow from $89.05 billion in 2024 to $94.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased stress and sleep disorders, aging population, lifestyle changes, awareness and education, consumer preference for natural remedies.

The sleeping aids market size is expected to see strong growth in the next few years. It will grow to $132.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to wellness and self-care trends, mental health awareness, home-based sleep solutions, personalized sleep solutions, natural and non-invasive options. Major trends in the forecast period include wellness and self-care emphasis, technological integration, sleep hygiene education, regulatory focus on safety.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of prescription-grade melatonin and non-benzodiazepine sedatives sourced from India and Canada, thereby reducing treatment adherence for insomnia patients and elevating mental health service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth trajectory of the sleeping aids market is expected to be significantly influenced by the increasing incidence of sleep disorders. Sleep disorders, stemming from insufficient sleep, have substantial implications for overall health. Sleeping aids play a crucial role as medications, not only in mitigating cognitive impairment resulting from sleep deprivation but also in promoting short-term improvements in sleep quality. Notably, as of January 2022, data from the National Center for Biotechnology Information reveals the prevalence of sleep problems in diverse populations, with rates projected at 52.39% for COVID-19 patients, 45.96% for children and adolescents, 42.47% for healthcare workers, 41.50% for special populations with healthcare needs, 41.16% for university students, and 36.73% for the general population. This observed rise in sleep disorders underscores the increasing demand for sleeping aids, positioning them as essential solutions.

The rising global aging population is anticipated to drive the growth of the sleeping aid market in the coming years. An aging population refers to changes in a demographic's age distribution that result in a larger proportion of elderly individuals. As people age, various age-related factors can lead to sleep disorders and disturbances, heightening the demand for sleep-related solutions. For example, in May 2024, the Administration for Community Living, a U.S.-based government agency, reported that in 2022, 17.3% of the population was aged 65 or older, with projections indicating that this figure will rise to 22% by 2040. Thus, the growing global aging population is a significant driver of the sleeping aid market.

A notable trend in the sleeping aids market is the emphasis on product innovations by major market players. The development of new products, including wearable sleep aids, serves as a strategic approach for market players to maintain their competitive edge. In March 2022, StimScience, a US-based company specializing in sleeping aids, introduced Somnee, a wearable sleep aid. This innovative product stands out as the first electronic sleep aid headband featuring personalized non-invasive brain stimulation. Results from a 1,500-night home pilot study indicate a remarkable improvement in sleep quality and a reduction of over one-third in overnight tossing and turning. This exemplifies the industry's commitment to advancing solutions and meeting evolving consumer needs through innovative product offerings in the sleeping aids market.

Major players in the sleeping aids manufacturing sector are actively engaging in strategic collaborations with prominent manufacturing companies, a move aimed at fortifying their market positions. Strategic collaborations provide companies with the opportunity to join forces with partners possessing the requisite expertise to translate conceptual ideas into tangible solutions. In October 2023, EnsoData, Inc., a leading US-based software company specializing in artificial intelligence (AI) solutions for sleep testing, diagnosis, and treatment, revealed a strategic partnership with React Health, a US-based manufacturer of sleep and respiratory devices. The collaboration is designed to enhance Positive Airway Pressure (PAP) adherence support for patients with sleep apnea. By leveraging actionable data, durable medical equipment suppliers, and referring doctors will have the means to provide prompt and personalized support to patients facing challenges in adhering to their treatment plans. This strategic partnership exemplifies a concerted effort to optimize patient care through innovative collaborations within the sleeping aids market.

In August 2022, ResMed Inc., a prominent US-based company focused on the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions, executed the acquisition of Mementor for an undisclosed amount. The acquisition underscores ResMed's commitment to digital health applications as an alternative to traditional pharmacological therapy, with the overarching goal of improving sleep quality. Mementor, a Germany-based consumer software developer specializing in sleep medicine, adds valuable capabilities to ResMed's portfolio, showcasing the company's dedication to expanding its offerings and staying at the forefront of advancements in sleep-related technologies. This strategic move exemplifies the industry's recognition of the importance of digital solutions in addressing sleep-related challenges and aligning with evolving consumer preferences.

Major companies operating in the sleeping aids market are Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Merck & Co. Inc., Natus Medical Incorporated, Novartis AG, Pfizer Inc., Sanofi SA, Sleepmed Inc., Eisai Co. Ltd., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Lowenstein Medical GmbH & Co. KG, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., AstraZeneca PLC, Apnea Sciences Corp., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc., Cadila Healthcare Limited, Johnson & Johnson Services Inc., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC

North America was the largest region in the sleeping aids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping aids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sleeping aids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sleeping aids market consists of sales of insomnia treatment drugs, quazepam, narcolepsy treatment drugs, modafinil, and sodium oxybate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sleeping Aids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sleeping aids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sleeping aids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleeping aids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sleeping Aids Market Characteristics

3. Sleeping Aids Market Trends And Strategies

4. Sleeping Aids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sleeping Aids Growth Analysis And Strategic Analysis Framework

6. Sleeping Aids Market Segmentation

7. Sleeping Aids Market Regional And Country Analysis

8. Asia-Pacific Sleeping Aids Market

9. China Sleeping Aids Market

10. India Sleeping Aids Market

11. Japan Sleeping Aids Market

12. Australia Sleeping Aids Market

13. Indonesia Sleeping Aids Market

14. South Korea Sleeping Aids Market

15. Western Europe Sleeping Aids Market

16. UK Sleeping Aids Market

17. Germany Sleeping Aids Market

18. France Sleeping Aids Market

19. Italy Sleeping Aids Market

20. Spain Sleeping Aids Market

21. Eastern Europe Sleeping Aids Market

22. Russia Sleeping Aids Market

23. North America Sleeping Aids Market

24. USA Sleeping Aids Market

25. Canada Sleeping Aids Market

26. South America Sleeping Aids Market

27. Brazil Sleeping Aids Market

28. Middle East Sleeping Aids Market

29. Africa Sleeping Aids Market

30. Sleeping Aids Market Competitive Landscape And Company Profiles

31. Sleeping Aids Market Other Major And Innovative Companies

32. Global Sleeping Aids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sleeping Aids Market

34. Recent Developments In The Sleeping Aids Market

35. Sleeping Aids Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기